Quoin Pharmaceuticals, Ltd.
About Quoin Pharmaceuticals, Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2021
- $0
- Net income
- -$15.8M
- Total assets
- $20.4M
- Market cap
- $9.0M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Net income
- -$15.8M
Balance sheet
- Total assets
- $20.4M
- Current assets
- $20.0M
- Total liabilities
- $7.3M
- Current liabilities
- $5.5M
- Shareholders’ equity
- $13.1M
Cash flow
- Operating cash flow
- -$13.5M
- Investing cash flow
- -$4.3M
- Financing cash flow
- $18.0M
- Net cash flow
- $195.4K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $9.0M
- Shares outstanding
- 1.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 28, 2021
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $15.8M in FY2021.
- Trading 77% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Quoin Pharmaceuticals, Ltd..
Write a review
News about Quoin Pharmaceuticals, Ltd.
News & sentiment via Polygon.io
